Follow
Christopher B. Fox
Christopher B. Fox
SVP, Formulations, Access to Advanced Health Institute
Verified email at aahi.org
Title
Cited by
Cited by
Year
Key roles of adjuvants in modern vaccines
SG Reed, MT Orr, CB Fox
Nature medicine 19 (12), 1597-1608, 2013
13582013
Use of defined TLR ligands as adjuvants within human vaccines
MS Duthie, HP Windish, CB Fox, SG Reed
Immunological reviews 239 (1), 178-196, 2011
4902011
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant
RN Coler, S Bertholet, M Moutaftsi, JA Guderian, HP Windish, SL Baldwin, ...
PloS one 6 (1), e16333, 2011
3972011
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
H HogenEsch, DT O’Hagan, CB Fox
npj Vaccines 3 (1), 51, 2018
2982018
Squalene emulsions for parenteral vaccine and drug delivery
CB Fox
Molecules 14 (9), 3286-3312, 2009
2562009
Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
NPH Knudsen, A Olsen, C Buonsanti, F Follmann, Y Zhang, RN Coler, ...
Scientific reports 6 (1), 19570, 2016
2392016
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
KO Saunders, E Lee, R Parks, DR Martinez, D Li, H Chen, RJ Edwards, ...
Nature 594 (7864), 553-559, 2021
2222021
New generation adjuvants–from empiricism to rational design
DT O’Hagan, CB Fox
Vaccine 33, B14-B20, 2015
1752015
An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
CB Fox, J Haensler
Expert review of vaccines 12 (7), 747-758, 2013
1482013
Detecting phase transitions in phosphatidylcholine vesicles by Raman microscopy and self-modeling curve resolution
CB Fox, RH Uibel, JM Harris
The Journal of Physical Chemistry B 111 (39), 11428-11436, 2007
1442007
A nanostructured lipid carrier for delivery of a replicating viral RNA provides single, low-dose protection against Zika
JH Erasmus, AP Khandhar, J Guderian, B Granger, J Archer, M Archer, ...
Molecular Therapy 26 (10), 2507-2522, 2018
1302018
Working together: interactions between vaccine antigens and adjuvants
CB Fox, RM Kramer, L Barnes V, QM Dowling, TS Vedvick
Therapeutic advances in vaccines 1 (1), 7-20, 2013
1242013
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
RC Anderson, CB Fox, TS Dutill, N Shaverdian, TL Evers, GR Poshusta, ...
Colloids and Surfaces B: Biointerfaces 75 (1), 123-132, 2010
1212010
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
MT Orr, CB Fox, SL Baldwin, SJ Sivananthan, E Lucas, S Lin, T Phan, ...
Journal of controlled release 172 (1), 190-200, 2013
1112013
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates
SP Kasturi, MAU Rasheed, C Havenar-Daughton, M Pham, T Legere, ...
Science immunology 5 (48), eabb1025, 2020
972020
Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions
CB Fox, RC Anderson, TS Dutill, Y Goto, SG Reed, TS Vedvick
Colloids and Surfaces B: Biointerfaces 65 (1), 98-105, 2008
972008
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
CB Fox, SJ Sivananthan, MS Duthie, J Vergara, JA Guderian, E Moon, ...
Journal of nanobiotechnology 12, 1-9, 2014
902014
Detection of drug− membrane interactions in individual phospholipid vesicles by confocal Raman microscopy
CB Fox, RA Horton, JM Harris
Analytical chemistry 78 (14), 4918-4924, 2006
902006
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
SM Alam, B Aussedat, Y Vohra, RR Meyerhoff, EM Cale, WE Walkowicz, ...
Science translational medicine 9 (381), eaai7521, 2017
892017
Adjuvants for Leishmania vaccines: from models to clinical application
VS Raman, SG Reed, MS Duthie, CB Fox, G Matlashewski
Frontiers in immunology 3, 23564, 2012
882012
The system can't perform the operation now. Try again later.
Articles 1–20